1Garber A J, Karlsson F O. Treatment of dyslipidemia in diabetes[J]. Endocrino and metab clin North Am, 2001, 30: 999.
2Marcus A O. Lipid disorders in patients with type 2 diabetes[J]. Postgraduate Med, 2001, 110(1): 111.
3American Diabetes Association. Management of dyslipidemia in adult with diabetes[J]. Diabetes Care, 2002, 25: S74.
4Sniderman A D, Lamarche B, Tilley J. Hypertriglyceridemic hyperapo B in type 2 diabetes[J]. Diabetes Care, 2002, 25: 579.
5Taskinen M R. Diabetic dyslipidemia[J]. Atheroscler(Suppl), 2002, 3(1): 47.
6Papadakis J A, Millionis H J. Treating dyslipidemia in non-insulin-dependent diabetes mellitus-a special reference to statins[J]. J Diabetes and its Complications, 2001, 15: 211.
7Goldberg I J. Diabetic dyslipidemia: cause and consequences[J]. J Clin EndocrinolMetab, 2001, 86(3): 965.
8Lacoste L, Lam J Y T. Comparative effect of pravastatin and simvastatin on platelet-thrombus formation in hypercholesterolemic coronary patients[J]. JACC, 1996, 27(suppl): 413.
9Paniagua J A, Berral F J, Barcos M. Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese Type 2diabetes[J]. Diabetes, 2002, 51: 2596.
10Shepherd J, Cobbe S M. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia[J]. N Engl J Med, 1995, 333: 1301.
